Childhood Rosacea
Clinical, Diagnostic, and Therapeutic Insights into an Underestimated Pediatric Condition.
Piccolo V, Nowowiejska-Purpurowicz J, Bassi A, Van Gysel D, Alexopoulos A, Kakourou T, Giorgio CM, Argenziano G
Dermatology Practical & ConceptualIn the feed 10 Oct 2026, published online 31 Jul 2026, issue 2026 Jul 31, added to PubMed 10 Oct 2026
Topics: RosaceaPediatric dermatology
Abstract
INTRODUCTIONRosacea is a very frequent skin disease; however, its prevalence in children is underestimated, and there are not enough data on this dermatosis in the pediatric population.
OBJECTIVEThis study aimed to give comprehensive insight into childhood rosacea (CR), pointing out predisposing factors, clinical presentation, diagnostic clues, and therapy of this subgroup of the disease spectrum.
METHODSThis is a narrative review of the existing data on rosacea in children.
RESULTSChildren affected by rosacea often present with recurrent erythema of the convex areas of the face as an early sign of the disease, mostly occurring after cold/heat/sun exposure or triggered by crying/playing/exercise. Phymatous lesions do not occur in children, and Morbihan disease has been very rarely reported. On the other hand, special rosacea subtypes, such as periorificial dermatitis, granulomatous rosacea, or idiopathic facial aseptic granuloma, are observed more often in children. The diagnosis is usually made based on the clinical picture; however, dermoscopy, and in some cases other imaging techniques, may aid the diagnosis. It is still a matter of debate whether a child affected by rosacea will become an adult with rosacea over time. The holistic approach to therapy of rosacea in children should include in particular the avoidance of triggering factors, proper skin care, and finally, adequate pharmacological treatment. Although procedural therapeutic options are frequently used in adults, their use in children should be tailored to the patient's age and discussed with the parents or caregivers.
CONCLUSIONRosacea may also occur in children. Therapeutic options do not significantly differ from those in adults; however, they must be adjusted to the child's age.
Abstract from PubMed
PMID 42858413 · DOI 10.5826/dpc.1603a7924